Axa’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,879
Closed -$246K 858
2025
Q2
$246K Buy
+5,879
New +$219K ﹤0.01% 1068
2024
Q3
Sell
-45,600
Closed -$2.02M 1133
2024
Q2
$2.02M Sell
45,600
-375
-0.8% -$16.8K 0.01% 751
2024
Q1
$2.02M Hold
45,975
0.01% 756
2023
Q4
$1.82M Buy
45,975
+1,400
+3% +$47.1K 0.01% 757
2023
Q3
$1.35M Sell
44,575
-1,000
-2% -$30K ﹤0.01% 790
2023
Q2
$1.35M Sell
45,575
-2,100
-4% -$60.7K ﹤0.01% 790
2023
Q1
$1.45M Buy
47,675
+300
+0.6% +$9.32K 0.01% 809
2022
Q4
$1.38M Hold
47,375
0.01% 833
2022
Q3
$1.25M Hold
47,375
﹤0.01% 827
2022
Q2
$1.48M Sell
47,375
-13,525
-22% -$474K 0.01% 818
2022
Q1
$2.12M Sell
60,900
-2,000
-3% -$66.1K 0.01% 817
2021
Q4
$2.21M Sell
62,900
-4,408
-7% -$155K 0.01% 825
2021
Q3
$2.34M Buy
67,308
+49,008
+268% +$1.5M 0.01% 829
2021
Q2
$515K Buy
+18,300
New +$545K ﹤0.01% 1102
2013
Q4
Sell
-17,600
Closed -$609K 1424
2013
Q3
$609K Sell
17,600
-2,600
-13% -$88.1K ﹤0.01% 963
2013
Q2
$646K Buy
+20,200
New +$612K ﹤0.01% 917

Other funds holding SCSC

Axa's SCSC Position: Q3 2025 in Review

Axa sold out of Scansource (SCSC) in Q3 2025, closing a stake of 5,879 shares — an estimated $246K sold.

Axa first reported a position in SCSC in Q2 2013 and held it in 16 quarters. The position peaked at $2.34M in Q3 2021. 219 funds tracked by Wall St. Rank hold SCSC as of Q3 2025.

  • Axa reported no remaining Scansource position as of Q3 2025 after selling out during the quarter.
  • Axa sold 5,879 Scansource shares in Q3 2025, an estimated $246K.
  • Axa first reported a position in Scansource in Q2 2013 and held it in 16 quarters.
  • Axa's Scansource position peaked at $2.34M in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Scansource as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.